Open AccessSupervised conventional interferon α2a in combination with ribavirin therapy is the preferred alternative for treatment of chronic hepatitis C
Author(s) -
Harmeet Singh Rehan,
Seema Manak,
Madhur Yadav
Publication year - 2014
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.140578
Subject(s) - ribavirin , medicine , interferon , gastroenterology , hepatitis c virus , chronic hepatitis , genotype , hepatitis c , combination therapy , immunology , virus , biology , gene , biochemistry
To document the significant sustained virological response with supervised conventional interferon α and ribavirin therapy in hepatitis C virus (HCV)-infected patients, this study was planned.